Antithrombotic compositions and medical instruments containing the same

• US 20040213818A1
• Filed: 04/26/2004
• Published: 10/28/2004
• Est. Priority Date: 06/05/2001
• Status: Abandoned Application

• Current Assignee: Toyoda Gosei Company Limited (Toyota Motor Corporation)
• Original Assignee: Toyoda Gosei Company Limited (Toyota Motor Corporation)
• Inventors: Sato, Masaki, Tanaka, Hidenori, Kashiwabara, Susumu
• Application Number:
  US10/479,596
• Publication Number:
  US 20040213818A1
• Time in Patent Office: Days
• US Class Current: 424/400
• CPC Class Codes: A61L 33/0011 Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
• CPC Class Codes: B29K 2067/00 Use of polyesters or derivatives thereof, as moulding material

Abstract

The present invention provides an antithrombotic composition containing an ionic complex formed from an organic cation mixture and heparin or a heparin derivative, wherein the organic cation mixture is a mixture of at least two ammonium salts, provided that the above-mentioned organic cation mixture is not a mixture of a didodecyldimethylammonium salt and at least one kind of an ammonium salt selected from ammonium salts having four aliphatic groups, wherein the four aliphatic groups have 30 to 38 carbon atoms in total and at least two of the four aliphatic groups are each an alkyl group having not less than 10 carbon atoms. This antithrombotic composition can impart superior antithrombotic property to a medical device over a prolonged period.

Claims

1-9. -9. (canceled)

10. An an tithrombotic composition comprising an ionic complex formed from an organic cation mixture and heparin or a heparin derivative, wherein the organic cation mixture is a mixture of at least two ammonium salts, provided that said organic cation mixture is not a mixture of a didodecyldimethylammonium salt and at least one kind of an ammonium salt selected from ammonium salts having four aliphatic groups, wherein the four aliphatic groups have 30 to 38 carbon atoms in total and at least two of the four aliphatic groups are each an alkyl group having not less than 10 carbon atoms.

11. The antithrombotic composition of claim 10, wherein the organic cation mixture is a mixture of at least one kind of (a) water-soluble ammonium salt, and at least one kind of (b) water-insoluble ammonium salt.

12. The antithrombotic composition of claim 11, wherein the (a) water-soluble ammonium salt is at least one kind of ammonium salt selected from a benzethonium salt and a benzalkonium salt.

13. The antithrombotic composition of claim 11, wherein the (b) water-insoluble ammonium salt is an ammonium salt wherein four aliphatic groups are bonded.

14. The antithrombotic composition of claim 12, wherein the (b) water-insoluble ammonium salt is an ammonium salt wherein four aliphatic groups are bonded.

15. The antithrombotic composition of claim 13, wherein two of the four aliphatic groups are each an alkyl group having not less than 12 carbon atoms.

16. The antithrombotic composition of claim 13, wherein three of the four aliphatic groups are each an alkyl group having not less than 10 carbon atoms.

17. The antithrombotic composition of claim 10, wherein the organic cation mixture is a mixture of at least one kind of (c) an ammonium salt below and at least one kind of (d) an ammonium salt below:

(c) an ammonium salt wherein four aliphatic groups are bonded, wherein the four aliphatic groups have not less than 40 carbon atoms in total, and at least two aliphatic groups are each an aliphatic alkyl group having not less than 12 carbon atoms,

(d) an ammonium salt wherein four aliphatic groups are bonded, wherein two of the four aliphatic group are each an aliphatic alkyl group having not more than 3 carbon atoms and the remaining two are each an aliphatic alkyl group having 10 to 14 carbon atoms.

18. The antithrombotic composition of claim 17, wherein the ammonium salt (c) is an ammonium salt wherein two of the four aliphatic groups are each an aliphatic alkyl group having not more than 2 carbon atoms, and the remaining two are each an aliphatic alkyl group having not less than 19 carbon atoms.

19. A medical device comprising the antithrombotic composition of claim 10, which is applied to at least a part of a blood-contacting surface.

20. The medical device of claim 19, wherein the organic cation mixture is a mixture of at least one kind of (a) water-soluble ammonium salt, and at least one kind of (b) water-insoluble ammonium salt.

21. The medical device of claim 20, wherein the (a) water-soluble ammonium salt is at least one kind of ammonium salt selected from a benzethonium salt and a benzalkonium salt.

22. The medical device of claim 20, wherein the (b) water-insoluble ammonium salt is an ammonium salt wherein four aliphatic groups are bonded.

23. The medical device of claim 21, wherein the (b) water-insoluble ammonium salt is an ammonium salt wherein four aliphatic groups are bonded.

24. The medical device of claim 22, wherein two of the four aliphatic groups are each an alkyl group having not less than 12 carbon atoms.

25. The medical device of claim 22, wherein three of the four aliphatic groups are each an alkyl group having not less than 10 carbon atoms.

26. The medical device of claim 19, wherein the organic cation mixture is a mixture of at least one kind of (c) an ammonium salt below and at least one kind of (d) an ammonium salt below:

(c) an ammonium salt wherein four aliphatic groups are bonded, wherein the four aliphatic groups have not less than 40 carbon atoms in total, and at least two aliphatic groups are each an aliphatic alkyl group having not less than 12 carbon atoms,

(d) an ammonium salt wherein four aliphatic groups are bonded, wherein two of the four aliphatic group are each an aliphatic alkyl group having not more than 3 carbon atoms and the remaining two are each an aliphatic alkyl group having 10 to 14 carbon atoms.

27. The medical device of claim 26, wherein the ammonium salt (c) is an ammonium salt wherein two of the four aliphatic groups are each an aliphatic alkyl group having not more than 2 carbon atoms, and the remaining two are each an aliphatic alkyl group having not less than 19 carbon atoms.